Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUNIC, INC. Director's Dealing 2014

Apr 23, 2014

10196_dirs_2014-04-23_a0d13904-8ea7-4203-959d-e52660d22d02.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2014-04-23

Reporting Person: Halperin Errol R. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-04-23 Common Stock P 8333 $12.00 Acquired 8333 Indirect
2014-04-23 Common Stock P 6191 $12.00 Acquired 6191 Indirect
2014-04-23 Common Stock C 39417 Acquired 45608 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-04-23 Senior Convertible Preferred Stock $ C 39417 Disposed Common Stock (39417) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 40000 Direct

Footnotes

F1: Shares held by Errol Halperin IRA FBO Errol Halperin

F2: Each share of Senior Convertible Preferred Stock automatically converted into the Registrant's common stock on a one-for-one basis immediately prior to the closing of the Registrant's initial public offering and had no expiration date.